← back to search

Claudio Bordignon

Hospital Moinhos de Vento ·
Area of research
Oncology · Genetics
Research interest
Research interests include Virus-based gene therapy research, CAR-T cell therapy research, Peptidase Inhibition and Analysis, and Hematopoietic Stem Cell Transplantation.
h-index
72
citations
23,063
works
413
NIH funding
primary concept
email

Recent publications

Tracking Genetically Engineered Lymphocytes Long-Term Reveals the Dynamics of T-Cell Immunological Memory
Blood 2015cited by 0position: middledoi
Long-Term Immunological Profile of Patients Treated with Haploidentical HSCT and TK-Cells to Study the Requirements of Memory T Cell Persistence
Blood 2014cited by 1position: middledoi
A four-arm randomized phase II trial with NGR-hTNF given at low or high dose with or without doxorubicin in soft tissue sarcomas (STS).
Journal of Clinical Oncology 2014cited by 0position: lastdoi
Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy
Science 2013cited by 1,193position: middledoi
CD44v6-targeted T cells mediate potent antitumor effects against acute myeloid leukemia and multiple myeloma
Blood 2013cited by 350position: middledoi
The oxysterol–CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophils
The Journal of Experimental Medicine 2013cited by 232position: middledoi
Two doses of NGR-hTNF (N) given alone or in combination with doxorubicin (D) in soft tissue sarcomas (STS).
Journal of Clinical Oncology 2013cited by 3position: lastdoi
Long-Term Immunological Profile and T Cell Dynamics In Patients Treated With Allogeneic Transplantation and TK-Cells For Hematological Malignancies
Blood 2013cited by 0position: middledoi
<i>De Novo</i> Design of a Tumor-Penetrating Peptide
Cancer Research 2012cited by 172position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 4 papers (2013–2015)Chiara Bonini · University of Rome Tor Vergata4 papers (2013–2015)Catia Traversari · Fondazione IRCCS Istituto Neurologico Carlo Besta4 papers (2012–2015)Fabio Ciceri · Vita-Salute San Raffaele University4 papers (2013–2015)Attilio Bondanza · Novartis (Switzerland)3 papers (2013–2015)Manfred Schmidt · Heidelberg University3 papers (2013–2015)Nicoletta Cieri · Massachusetts Institute of Technology3 papers (2013–2015)Christof von Kalle · Luxembourg Institute of Health3 papers (2013–2015)Maria Teresa Lupo Stanghellini · Technical University of Munich3 papers (2013–2015)Giacomo Oliveira · Harvard University3 papers (2013–2015)Raffaella Greco · IRCCS Ospedale San Raffaele3 papers (2013–2015)Eliana Ruggiero · Vita-Salute San Raffaele University3 papers (2013–2015)Luca Vago · Gene Therapy Laboratory3 papers (2013–2015)Luca Biasco · Institute of Infection and Immunity2 papers (2014–2015)Alessandro Aiuti · Vita-Salute San Raffaele University2 papers (2014–2015) · 2 papers (2013–2014)Emanuela Palmerini · Istituto Ortopedico Rizzoli2 papers (2013–2014)Axel Le Cesne · Institut Gustave Roussy2 papers (2013–2014) · 2 papers (2013–2014)Mattia D’Agostino · Azienda Ospedaliera Citta' della Salute e della Scienza di Torino2 papers (2014–2015)